Lorelei Mucci

Dr Mucci is a cancer epidemiologist with more than ten years of research and teaching experience. She is an Associate Professor of Epidemiology at the Harvard School of Public Health and lead the Cancer Epidemiology program at the Dana Farber/Harvard Cancer Center (DF/HCC).

Her research has focused on biomarker studies investigating the etiology of cancer risk as well as studying lifestyle and molecular factors associated with cancer progression. Over the past eight years, her research focus has turned to prostate cancer tumour biomarkers.

Dr Mucci is Principal Investigator of several funded grants across various aspects of prostate cancer etiology, molecular subclassification and prognostication. She led the tumour biorepositories of 3,000 prostate cancer patients who are participants in the Physicians’ Health Study and the Health Professionals Follow-up Study. Moreover, she is co-leader of a multi-disciplinary, international prostate cancer patho-epidemiology collaboration of researchers at Harvard as well as medical institutions in Sweden, Iceland, Ireland and Italy.

Dr Mucci’s research includes studies focused on immunohistochemistry and large-scale genome wide expression profiling study within large cohorts of men with prostate cancer. Teaching and mentoring has been a core component of her academic work. She has mentored of 25 graduate students, post-doctoral fellows and clinical fellows, and served as co-Director of a peer-mentoring program of 40 fellows and instructors.

Education

• Harvard T.H. Chan School of Public Health - ScD, Epidemiology
• Tufts University - BS, Biology